Search

Your search keyword '"Sadler, Ross"' showing total 52 results

Search Constraints

Start Over You searched for: Author "Sadler, Ross" Remove constraint Author: "Sadler, Ross" Database MEDLINE Remove constraint Database: MEDLINE
52 results on '"Sadler, Ross"'

Search Results

1. Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma.

2. Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination.

3. Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia.

4. Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services.

5. Leaching characteristics and potential risk of heavy metals from drip irrigation pipes and mulch substrate in agricultural ecosystems.

6. 11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial.

7. Environmental monitoring and potential health risk assessment from Pymetrozine exposure among communities in typical rice-growing areas of China.

8. Exposure Routes and Health Risks Associated with Pesticide Application.

9. Bedside and laboratory diagnostic testing in myasthenia.

10. Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T-cell response.

11. Natural dynamics and residues of pymetrozine for typical rice-growing areas of China.

12. COVID symptoms, testing, shielding impact on patient-reported outcomes and early vaccine responses in individuals with multiple myeloma.

13. Probabilistic health risk assessment of chlorpyrifos exposure among applicators on rice farms in Ghana.

14. Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic.

15. Using quantitative immunoprecipitation mass spectrometry (QIP-MS) to identify low level monoclonal proteins.

16. Improving the diagnostic pathway in patients presenting with acute kidney injury secondary to de novo multiple myeloma: a short report.

17. Health Risk Assessment for Exposure to Nitrate in Drinking Water in Central Java, Indonesia.

18. Agriculture Development, Pesticide Application and Its Impact on the Environment.

19. Epidemiology of soil-transmitted helminth infections in Semarang, Central Java, Indonesia.

20. Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related disease.

21. Impacts of helmet law on the changes in potential years of life lost due to traffic injury: a multiple-province evaluation in Vietnam.

23. Impact of the "BALatrine" Intervention on Soil-Transmitted Helminth Infections in Central Java, Indonesia: A Pilot Study.

25. Testing and management for monoclonal gammopathy of uncertain significance and myeloma patients presenting with osteoporosis and fragility fractures.

26. Comparative evaluation of chlorpyrifos exposure estimates from whole-body dermal dosimetry and urinary trichloro-2-pyridinol (TCP) methods.

27. Difference of trace element exposed routes and their health risks between agriculture and pastoral areas in Bay County Xinjiang, China.

28. Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis.

29. Biomonitoring of chlorpyrifos exposure and health risk assessment among applicators on rice farms in Ghana.

30. Health risk assessment of dermal exposure to chlorpyrifos among applicators on rice farms in Ghana.

31. Increases in IgE, Eosinophils, and Mast Cells Can be Used in Diagnosis and to Predict Relapse of IgG4-Related Disease.

32. Dermal exposure of applicators to chlorpyrifos on rice farms in Ghana.

33. No evidence to support a role for Helicobacter pylori infection and plasminogen binding protein in autoimmune pancreatitis and IgG4-related disease in a UK cohort.

34. Health risk assessment for exposure to nitrate in drinking water from village wells in Semarang, Indonesia.

35. Elevated Serum IgG4 Levels in Diagnosis, Treatment Response, Organ Involvement, and Relapse in a Prospective IgG4-Related Disease UK Cohort.

36. Bioavailability study of arsenic and mercury in traditional Chinese medicines (TCM) using an animal model after a single dose exposure.

37. Worm-free children: an integrated approach to reduction of soil-transmitted helminth infections in Central Java.

38. Hypomorphic function and somatic reversion of DOCK8 cause combined immunodeficiency without hyper-IgE.

39. Increased IgG4 responses to multiple food and animal antigens indicate a polyclonal expansion and differentiation of pre-existing B cells in IgG4-related disease.

40. Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease.

41. Establishment of a healthy human range for the whole blood "OX40" assay for the detection of antigen-specific CD4+ T cells by flow cytometry.

42. Serum-free light-chain assay: clinical utility and limitations.

43. Circulating levels of cell-derived microparticles are reduced by mild hypobaric hypoxia: data from a randomised controlled trial.

44. Establishment of a healthy human range for the whole blood 'OX40' assay for the detection of antigen-specific CD4+ T cells by flow cytometry.

45. First report of a toxic Nodularia spumigena (Nostocales/ Cyanobacteria) bloom in sub-tropical Australia. I. Phycological and public health investigations.

46. First report of a toxic Nodularia spumigena (Nostocales/ Cyanobacteria) bloom in sub-tropical Australia. II. Bioaccumulation of nodularin in isolated populations of mullet (Mugilidae).

47. The diagnostic significance of serum IgG4 levels in patients with autoimmune pancreatitis: a UK study.

48. Consistent chemical form of Cd in liver and kidney tissues in rats dosed with a range of Cd treatments: XAS of intact tissues.

49. Establishing a public health analytical service based on chemical methods for detecting and quantifying Pacific ciguatoxin in fish samples.

50. Occupational and environmental hazard assessments for the isolation, purification and toxicity testing of cyanobacterial toxins.

Catalog

Books, media, physical & digital resources